Author Correction: The efficacy of chemotherapy is limited by intratumoral senescent cells expressing PD-L2.
Saved in:
| Title: | Author Correction: The efficacy of chemotherapy is limited by intratumoral senescent cells expressing PD-L2. |
|---|---|
| Authors: | Chaib S; Institute for Research in Biomedicine, Barcelona Institute of Science and Technology, Barcelona, Spain.; Division of General Internal Medicine, Mayo Clinic, Rochester, MN, USA., López-Domínguez JA; Institute for Research in Biomedicine, Barcelona Institute of Science and Technology, Barcelona, Spain. josealberto.lopez@irbbarcelona.org., Lalinde-Gutiérrez M; Vall d'Hebron Institute of Oncology, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain., Prats N; Institute for Research in Biomedicine, Barcelona Institute of Science and Technology, Barcelona, Spain., Marin I; Institute for Research in Biomedicine, Barcelona Institute of Science and Technology, Barcelona, Spain.; Genentech, South San Francisco, CA, USA., Boix O; Vall d'Hebron Institute of Oncology, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain., García-Garijo A; Vall d'Hebron Institute of Oncology, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain., Meyer K; Institute for Research in Biomedicine, Barcelona Institute of Science and Technology, Barcelona, Spain.; Cambridge Institute of Science, Altos Labs, Cambridge, UK., Muñoz MI; Institute for Research in Biomedicine, Barcelona Institute of Science and Technology, Barcelona, Spain., Aguilera M; Institute for Research in Biomedicine, Barcelona Institute of Science and Technology, Barcelona, Spain., Mateo L; Institute for Research in Biomedicine, Barcelona Institute of Science and Technology, Barcelona, Spain., Stephan-Otto Attolini C; Institute for Research in Biomedicine, Barcelona Institute of Science and Technology, Barcelona, Spain., Llanos S; DNA Replication Group, Spanish National Cancer Research Center, Madrid, Spain., Pérez-Ramos S; Vall d'Hebron Institute of Oncology, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain., Escorihuela M; Vall d'Hebron Institute of Oncology, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain., Al-Shahrour F; Bioinformatics Unit, Spanish National Cancer Research Center, Madrid, Spain., Cash TP; Rejuveron Senescence Therapeutics, Zürich, Switzerland., Tchkonia T; Department of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, MN, USA., Kirkland JL; Division of General Internal Medicine, Mayo Clinic, Rochester, MN, USA.; Department of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, MN, USA., Abad M; Vall d'Hebron Institute of Oncology, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.; Cambridge Institute of Science, Altos Labs, Cambridge, UK., Gros A; Vall d'Hebron Institute of Oncology, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain., Arribas J; Vall d'Hebron Institute of Oncology, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.; Cancer Research Program, Hospital del Mar Medical Research Institute, Centro de Investigación Biomédica en Red Cáncer, Barcelona, Spain.; Department of Medicine and Life Sciences, Universitat Pompeu Fabra, Barcelona, Spain.; Institució Catalana de Recerca i Estudis Avançats, Barcelona, Spain., Serrano M; Institute for Research in Biomedicine, Barcelona Institute of Science and Technology, Barcelona, Spain. mserrano@altoslabs.com.; Cambridge Institute of Science, Altos Labs, Cambridge, UK. mserrano@altoslabs.com.; Institució Catalana de Recerca i Estudis Avançats, Barcelona, Spain. mserrano@altoslabs.com. |
| Source: | Nature cancer [Nat Cancer] 2026 May 29. Date of Electronic Publication: 2026 May 29. |
| Publication Type: | Published Erratum |
| Journal Info: | Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101761119 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2662-1347 (Electronic) Linking ISSN: 26621347 NLM ISO Abbreviation: Nat Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
